Replies to post #2779 on Ayala Pharmaceuticals Inc (ADXS)

[MrDanMan]

Your frustration is warranted rmarc, management has been incompetent. Advaxis` science is credible, however they are still early in clinical stages. As much as I`d love for funding sources to be knocking on our door, an orphan drug candidate (not even granted approval) in Phase II trials isn`t going to have many bidders. Just not sexy enough. It`s management job to go out and sell the story in exchange for legitimate financing. This is where I feel Moore failed us. This is also why I have hope in Dan O`Connor. If his past experience is any indication, the man can sell.

[stills999]

Your post seemed to be making a definitive conclusion about the science, so I was just curious if you had any specific insights about the science or rather just inductive reasoning/speculation ... thanks for the clarification that you were making the latter.